variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Heterozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G
HFE-H63D,HFE,"There have been some hypotheses that this variant contributes to causing hereditary hemochromatosis, possibly as a compound heterozygote, but some others treat it as a polymorphism. Cys282Tyr is the classic causal variant and itself has very low penetrance. Mouse studies indicates this variant has a similar but weaker effect; if it has any effect at all its penetrance may be quite low and/or require modifier alleles.",Low,Uncertain,Pathogenic,0.11,Blood,Recessive,Heterozygous,8696333;9462220;12429850;14673107;17042772,rs1799945,1,chr6,26091179,G
DYX1C1-E417X,DYX1C1,"One study reports this variant to be associated with dyslexia. The study group was relatively small and so the results did not have strong significance. If they are representative this variant is associated with a doubled risk for dyslexia, but it is unclear whether the effect would be additive, dominant, or recessive.",Low,Uncertain,Pathogenic,0.2,Mental and behavioral,Unknown,Homozygous,12954984,rs57809907,3,chr15,55722882,A
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A
ITPA-P32T,ITPA,"This variant is associated with inosine triphosphate pyrophosphohydrolase deficiency and may be associated with an adverse reaction to thiopurine drugs (which are used as immunosuppressants). Homozygotes have no detectable ITPase activity, individuals compound heterozygous with another less severe mutation also have severely reduced enzyme activity.",Low,Well-established,Pharmacogenetic,0.061,Drug response;Immune system;Metabolism,Recessive,Heterozygous,12384777;15322947;17924837;19631656;19682085;20173735,rs1127354,1,chr20,3193842,A
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Heterozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Homozygous,19887537,rs1805097,,chr13,110435231,T
TYR-R402Q,TYR,"This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.",Low,Well-established,Benign,0.2,Hearing and vision,Complex/Other,Heterozygous,1820207;7704033;11284711;18326704;18488027;18488028;19533789,rs1126809,0,chr11,89017961,A
PKHD1-I3905N,PKHD1,"Presumed benign, allele frequency contradicts severe pathogenic effect.",Low,Likely,Benign,0.049,Other,Unknown,Homozygous,,rs2661488,,chr6,51491866,T
COL6A3-D2831H,COL6A3,"Probably benign, reported by Pan et al. as a presumed-nonpathogenic variant in the gene.",Low,Likely,Benign,0.068,Other,Unknown,Heterozygous,9536084;15563506,rs36104025,,chr2,238247734,G
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Homozygous,,rs12742169,,chr1,201052310,T
ADA-K80R,ADA,"This variant has a 3.5% allele frequency in 1000 genomes data. Although OMIM links this to disease, the paper they reference uses in vitro data to conclude that this is a functionally neutral polymorphism.",Low,Likely,Benign,0.064,Other,Recessive,Heterozygous,6198631;17181544,rs11555566,,chr20,43255220,C
FLT4-N149D,FLT4,"Other severe variants in this gene are implicated in causing Milroy Disease (primary lymphedema) in a recessive manner. Although this variant is rare (2.3% allele frequency), it is still common enough that it is highly unlikely to have a severe, high penetrance pathogenic effect.",Low,Likely,Benign,0.073,Blood,Unknown,Homozygous,11292664,rs34221241,,chr5,180057293,C
RYR2-G1885E,RYR2,"Hypothesized to cause arrhythmogenic right ventricular cardiomyopathy when compound heterozygous with G1886S. However, this variant is quite common (2.4% in Europeans), as is G1886S (3.1% in Europeans), and about 1 in 700 are compound heterozygous. This is highly discordant with a disease prevalence of 1 in 2500 to 5000, and notably G1886S is reported in ClinVar as benign. We should consider the original hypothesis disproven.",Low,Likely,Benign,0.018,"Heart and circulatory;Muscular, skeletal, and connective tissue;Nervous system",Recessive,Heterozygous,16769042;18326664,rs41315858,4,chr1,237778082,A
EFHC1-R182H,EFHC1,Probably benign. OMIM appears to incorrectly interpret literature as linking this variant to juvenile myoclonic epilepsy; the authors report it as a polymorphism.,Low,Likely,Benign,0.044,Nervous system,Unknown,Heterozygous,7668263;15258581,rs3804505,,chr6,52303361,A
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G
LOXL1-R141L,LOXL1,"Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.",Low,Uncertain,Benign,0.26,Hearing and vision,Complex/Other,Heterozygous,17690259;18450598;20142848,rs1048661,,chr15,74219546,T
COL7A1-P1277L,COL7A1,"Polymorphism, presumed benign.",Low,Uncertain,Benign,0.041,Other,Unknown,Heterozygous,,rs35761247,,chr3,48623124,A
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A
MLH3-E624Q,MLH3,"Probably benign, follow-up studies have failed to support any link with colorectal cancer and the protein function is identical to wildtype.",Low,Uncertain,Benign,0.0082,Cancer,Unknown,Heterozygous,11586295;12702580;19156873,rs28756986,,chr14,75514489,G
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Heterozygous,17952075;17999355,rs1042602,,chr11,88911696,A
TERT-A279T,TERT,Reported as a rare but probably nonpathogenic polymorphism occurring in controls as well as patients. Other defects in this gene are associated with telomere shortening which may cause aplastic anemia or dyskeratosis congenita.,Low,Uncertain,Benign,0.02,Blood,Unknown,Heterozygous,15814878;18931339,rs61748181,,chr5,1294166,T
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Heterozygous,19351729,rs505151,,chr1,55529187,A
FLG-R3530S,FLG,"Tentatively classified as benign, although predicted by Polyphen 2 to be damaging. Other more severe null mutations (frameshift and nonsense) in this gene are reported to cause ichthyosis vulgaris in a recessive manner.",Low,Uncertain,Benign,0.11,Skin,Unknown,Heterozygous,,rs72697000,,chr1,152276772,A
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C
ABCC11-G180R,ABCC11,This variant is associated with dry type ear wax (a benign trait) in a recessive manner.,Low,Uncertain,Benign,0.098,Other,Unknown,Heterozygous,14471313;16444273,rs17822931,,chr16,48258198,T
MUSK-T100M,MUSK,Probably benign.,Low,Uncertain,Benign,0.023,Other,Unknown,Heterozygous,,rs35142681,,chr9,113449489,T
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Heterozygous,19955750,rs1046116,,chr12,33021934,G
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G
